ASCO 2026 - Breast Cancer Highlights with Dr. Nathalie LeVasseur

Dr. Nathalie LeVasseur reviews key ASCO 2025 updates in early breast cancer, highlighting emerging evidence supporting treatment optimization, opportunities for de-escalation in biologically low-risk disease, and the growing role of metabolic and lifestyle interventions in improving patient outcomes.